MedTrace Logo

Radiotherapy Treatments for Neoplasms in the Head and Neck Region

NCT06335342 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 4050

Last updated 2024-08-05

No results posted yet for this study

Summary

The aim of this study is the evaluation of clinical and dosimetric aspects, tolerance, and effectiveness of radiotherapy treatments in the head and neck region.

Eligible patients undergoing radiotherapy for primary or secondary neoplasms localized in the head and neck anatomical region.

Conditions

  • Head and Neck Neoplasms

Sponsors & Collaborators

  • European Institute of Oncology

    lead OTHER

Principal Investigators

  • Barbara Alicja Jereczek · European Institute of Oncology

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-02-22
Primary Completion
2024-12-31
Completion
2024-12-31

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06335342 on ClinicalTrials.gov